Terra Quantum, a global leader in quantum technology, today announced a new method for predicting molecular structures with improved efficiency and speed in a joint research effort with Prof. Dr. Christoph Bannwarth of RWTH Aachen University, the largest technical university in Germany. The quantum tensor network-based approach demonstrated a 5X to 20X speed-up in determining the molecular structure, over classical approaches.

D-Wave Quantum, a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, and the pharmaceutical division of Japan Tobacco Inc. today announced plans to collaborate on a joint proof-of-concept project that will leverage quantum computing technology and artificial intelligence (“AI”) in the drug discovery process, i.e., “Quantum AI-driven Drug Discovery.”

Infleqtion, the world’s leading quantum information company, today announced it has been awarded a $1.15M grant by the Department of Energy (DOE) under the SBIR Phase IIB program. This grant marks the first DOE SBIR Phase IIB award given to software for quantum computing and will help advance Infleqtion’s work on Superstaq, the company’s software platform purpose-built to optimize quantum computing performance.

Phasecraft, the UK quantum company developing world-leading quantum algorithms, today publishes a white paper examining the near-term future of quantum computing. While acknowledging the field’s significant progress, the paper highlights the challenges ahead and calls for sustained investment, international collaboration, and responsible regulation.

QuEra Computing, the leader in neutral-atom quantum computing, and Quantum Intelligence Corp. (QIC), a South Korean pioneer in AI-driven drug development, have announced a strategic partnership. This collaboration is set to transform the way drugs are discovered and developed by harnessing QuEra's cutting-edge neutral atom-type quantum computers.

Polaris Quantum Biotech (PolarisQB), a leader in Quantum Computing for drug discovery, is announcing the integration of Virtual Libraries and Fragmentation schemes from chemical technology innovator Liverpool ChiroChem into their Quantum-Aided Drug Design (QuADD) platform.

In a new initiative that blends innovation in quantum technologies and artificial intelligence (AI) with clinical applications, the Novo Nordisk Foundation (NNF), together with Cleveland Clinic, has launched the Cleveland Clinic – Denmark: Quantum-AI Biomedical Frontiers Fellowship Program.

D-Wave Quantum today announced it is strengthening the connection between quantum optimization, artificial intelligence (AI), and machine learning (ML), by extending its product development roadmap with enhancements to the Leap quantum cloud service that will bring new Quantum AI solutions to market.

Quantum Transistors, a pioneer in advanced quantum processor development, has been awarded up to €17.5 million by the European Innovation Council (EIC). Quantum Transistors received an initial grant from the EIC Accelerator of €2.5 million combined with a future equity investment of €15 million through the EIC Fund.

Yonsei University has signed a Memorandum of Understanding (MOU) with IBM for the 'MOU for Cooperation on the Bio-Quantum Initiative'. This agreement aims to strengthen collaboration between the two institutions in the research and development of quantum computing within the field of biotechnology.